CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

Evalition Expression of mir-30-3p in breast cancer

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 129
Year: 2016
COI code: IPMCMED01_163
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Evalition Expression of mir-30-3p in breast cancer

Nasrin Noshadi - Marvdasht Azad Universtiy
Asghar Arshi - Young Researchers and Elite Club, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran

Abstract:

Background: microRNAs are short non-coding RNAs (20-24 nt) that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miR-30-3p has been reported to be a tumor suppressor and a promising therapeutic target in cancer. miR-30-3p has been associated with epithelial mesenchymal transition and chemo-resistance in cancer. The aim of this study is to investigate the expression of miR-30-3p, its prognostic roles and its potential targets in breast cancer by RT-qPCR.Methods: In the present case-control study, 20 tissue samples from patients with breast cancer and 20 tissue samples from healthy group under the direct supervision of a pathologist specialist due to clinical presentation and laboratory findings were collected. After extracting RNA from normal and tumor blood samples, cDNA synthesis method according to the protocol and RT-qPCR was performed. mir-30-3p expression level was calculated using Livak method. All data were analyzed using SPSS software.Results: The results of RT-qPCR indicated miR-200b was downregulated in breast cancer tissues and its low-expression correlated with poor outcome in breast cancer patients. Expression level of mir-30-3p was 31.24% and 68.76% in breast cancer patients and healthy group respectively (p value=0.001).Conclusion: Due to the previous reports, mir-30-3p act as tumor suppressor in breast cancer, which could be used as biomarker for breast cancer diagnosis. In this study we propose that miR-30-3p is a potential diagnostic marker and therapeutic target of breast cancer.

Keywords:

breast cancer, microRNA, mir-30-3p, RT-qPCR

Perma Link

https://www.civilica.com/Paper-IPMCMED01-IPMCMED01_163.html
COI code: IPMCMED01_163

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Noshadi, Nasrin & Asghar Arshi, 2016, Evalition Expression of mir-30-3p in breast cancer, First Personal Medical Congress, تهران, دانشگاه علوم پزشكي ايران - پژوهشكده ملي مهندسي ژنتيك و زيست فناوري ايران، مركز همكاري هاي فناوري و نوآوري هاي رياست جمهوري, https://www.civilica.com/Paper-IPMCMED01-IPMCMED01_163.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Noshadi, Nasrin & Asghar Arshi, 2016)
Second and more: (Noshadi & Arshi, 2016)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.